T1	Participants 372 423	patients with cerebral ischaemia of arterial origin
T2	Participants 719 750	planned to enroll 4500 patients
T3	Participants 959 1097	international, multicentre study in which 60-80 hospitals in the Netherlands and other countries in Europe and Australia will participate.
